Chemoinformaics analysis of Cyclopentanone
| Molecular Weight | 84.118 | nRot | 0 |
| Heavy Atom Molecular Weight | 76.054 | nRig | 6 |
| Exact Molecular Weight | 84.0575 | nRing | 1 |
| Solubility: LogS | 0.178 | nHRing | 0 |
| Solubility: LogP | 0.403 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 14 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 14.4863 |
| nHD | 0 | BPOL | 8.89366 |
| QED | 0.43 |
| Synth | 2.113 |
| Natural Product Likeliness | 0.712 |
| NR-PPAR-gamma | 0.788 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.028 |
| Pgp-sub | 0.012 |
| HIA | 0.005 |
| CACO-2 | -4.378 |
| MDCK | 0.0000274 |
| BBB | 0.993 |
| PPB | 0.318653 |
| VDSS | 0.723 |
| FU | 0.742935 |
| CYP1A2-inh | 0.187 |
| CYP1A2-sub | 0.789 |
| CYP2c19-inh | 0.048 |
| CYP2c19-sub | 0.368 |
| CYP2c9-inh | 0.018 |
| CYP2c9-sub | 0.683 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.824 |
| CYP3a4-inh | 0.009 |
| CYP3a4-sub | 0.176 |
| CL | 7.549 |
| T12 | 0.889 |
| hERG | 0.014 |
| Ames | 0.444 |
| ROA | 0.071 |
| SkinSen | 0.188 |
| Carcinogencity | 0.133 |
| EI | 0.987 |
| Respiratory | 0.206 |
| NR-Aromatase | 0.017 |
| Antiviral | No |
| Prediction | 0.954861 |